JV - Award for Best Belgian Sustainability Report

context of HIV prevention trials. Am J Reprod Immunol 2011;65(3):368-76.Keugoung B, Macq J, Buvé A, Meli J, Criel B. The interface betweenhealth systems and vertical programmes in Francophone Africa: themanagers’ perceptions. Trop Med Int Health 2011;16(4):478-85.Laga M, Vuylsteke B. Evaluating AVAHAN’s design, implementation andimpact: lessons learned for the HIV prevention community. BMC PublicHealth 2011;11(Suppl. 6):S16.Lienhardt C, Cook SV, Burgos M, Yorke-Edwards V, Rigouts L, Anyo G,Kim SJ, Jindani A, Enarson DA, Nunn AJ. Efficacy and safety of a 4-drugfixed-dose combination regimen compared with separate drugsfor treatment of pulmonary tuberculosis: the Study C randomizedcontrolled trial. JAMA 2011;305(14):1415-23.Martin A, Bombeeck D, Mulders W, Fissette K, De Rijk P, PalominoJC. Evaluation of the TB Ag MPT64 rapid test for the identificationof Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis2011;15(5):703-5.Martin A, Paasch F, Docx S, Fissette K, Imperiale B, Ribón W, GonzalezLA, Werngren J, Engström A, Skenders G, Juréen P, Hoffner S, DelPortillo P, Morcillo N, Palomino JC. Multicentre laboratory validationof the colorimetric redox indicator (CRI) assay for the rapid detectionof extensively drug-resistant (XDR) Mycobacterium tuberculosis. JAntimicrob Chemother 2011;66(4):827-33.Martin A, Bombeeck D, Fissette K, De Rijk P, Hernández-Neuta I, DelPortillo P, Palomino JC. Evaluation of the BD MGIT TBc IdentificationTest (TBc ID), a rapid chromatographic immunoassay for the detectionof Mycobacterium tuberculosis complex from liquid culture. J MicrobiolMethods 2011;84(2):255-7.Minime-Lingoupou F, Manirakiza A, Yango F, Zandanga G, Le Faou A,Rigouts L. Relatively low primary resistance to anti-tuberculosis drugsin Bangui and Bimbo, Central African Republic. Int J Tuberc Lung Dis2011;15(5):657-61.Montague BT, Vuylsteke B, Buvé A. Sustainability of programs to reachhigh risk and marginalized populations living with HIV in resourcelimited settings: implications for HIV treatment and prevention[commentary]. BMC Public Health 2011;11(701):1-2.Mous K, Jennes W, De Roo A, Pintelon I, Kestens L, Van Ostade X.Intracellular detection of differential APOBEC3G, TRIM5alpha, andLEDGF/p75 protein expression in peripheral blood by flow cytometry.J Immunol Methods 2011;372(1-2):52-64.Muvunyi CM, Dhont N, Verhelst R, Crucitti T, Reijans M, MuldersB, Simons G, Temmerman M, Claeys G, Padalko E. Evaluation of anew multiplex polymerase chain reaction assay STDFinder for thesimultaneous detection of 7 sexually transmitted disease pathogens.Diagn Microbiol Infect Dis 2011;71(1):29-37.Njue C, Voeten HACM, Remes P. Porn video shows, local brew, andtransactional sex: HIV risk among youth in Kisumu, Kenya. BMC PublicHealth 2011;11(635):1-7.Nöstlinger C, Nideröst S, Platteau T, Müller MC, Staneková D, GredigD, Roulin C, Rickenbach M, Colebunders R. Sexual protection behaviorin HIV-positive gay men: testing a modified information-motivationbehavioralskills model. Arch Sex Behav 2011;40(4):817-27.Olusoji D, Eltayeb O, Adebiyi P, Gumusboga M, Declarq E, Bakare R. Nontuberculous mycobacteria isolates among new and previously treatedpulmonary tuberculosis patients in Nigeria. Asian Pacific J Trop Dis2011;1(2):113-5.Orroth KK, White RG, Freeman EE, Bakker R, Buvé A, Glynn JR, HabbemaJDF, Hayes RJ. Attempting to explain heterogeneous HIV epidemicsin sub-Saharan Africa: potential role of historical changes in riskbehaviour and male circumcision. Sex Transm Infect 2011;87(7):640-5.Otero L, Van Deun A, Agapito J, Ugaz R, Prellwitz G, Gotuzzo E, Vander Stuyft P. Quality assessment of smear microscopy by stratifiedlot sampling of treatment follow-up slides. Int J Tuberc Lung Dis2011;15(2):211-6.Ouakad M, Vanaerschot M, Rijal S, Sundar S, Speybroeck N, KestensL, Boel L, De Doncker S, Maes I, Decuypere S, Dujardin JC. Increasedmetacyclogenesis of antimony-resistant Leishmania donovani clinicallines. Parasitology 2011;138(11):1392-9.Phanzu DM, Mahema RL, Suykerbuyk P, Imposo DH, Lehman LF,Nduwamahoro E, Meyers WM, Boelaert M, Portaels F. Mycobacteriumulcerans infection (Buruli Ulcer) on the face: a comparative analysis of13 clinically suspected cases from the Democratic Republic of Congo.Am J Trop Med Hyg 2011;85(6):1100-5.Phanzu DM, Suykerbuyk P, Imposo DBB, Lukanu PN, Minuku JBM,Lehman LF, Saunderson P, de Jong BC, Lutumba PT, Portaels F, BoelaertM. Effect of a control project on clinical profiles and outcomes in Buruliulcer: a before/after study in Bas-Congo, Democratic Republic ofCongo. PLoS Negl Trop Dis 2011;5(12):e1402.Proaño-Pérez F, Benítez-Ortiz W, Portaels F, Rigouts L, Linden A.Situation of bovine tuberculosis in Ecuador. Rev Panam Salud Publica2011;30(3):279-86.Proaño-Pérez F, Benitez-Ortiz W, Desmecht D, Coral M, Ortiz J, RonL, Portaels F, Rigouts L, Linden A. Post-mortem examination andlaboratory-based analysis for the diagnosis of bovine tuberculosisamong dairy cattle in Ecuador. Prev Vet Med 2011;101(1-2):65-72.Ravinetto R, Buvé A, Halidou T, Lutumba P, Talisuna A, Juffrie M,D’Alessandro U, Boelaert M. Double ethical review of North-Southcollaborative clinical research: hidden paternalism or real partnership?[viewpoint]. Trop Med Int Health 2011;16(4):527-30.Richard F, Hercot D, Ouédraogo C, Delvaux T, Samake S, van Olmen J,Conombo G, Hammonds R, Vandemoortele J. Sub-Saharan Africa andthe health MDGs: the need to move beyond the “quick impact” model.Reprod Health Matters 2011;19(38):42-55.Rigouts L, Hoza AS, De Rijk P, Torrea G, Chonde TM, Basra D, Zignol M,van Leth F, Egwaga SM, Van Deun A. Evaluation of the Genotype(R)MTBDRplus assay as a tool for drug resistance surveys. Int J TubercLung Dis 2011;15(7):959-65.Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, Bartos M,Ghys PD, Opuni M, Barr D, Alsallaq R, Bollinger L, de Freitas M, GarnettG, Holmes C, Legins K, Pillay Y, Stanciole AE, McClure C, Hirnschall G,Laga M, Padian N. Towards an improved investment approach for aneffective response to HIV/AIDS. Lancet 2011;377(9782):2031-41.Selhorst P, Vazquez AC, Terrazas-Aranda K, Michiels J, Vereecken K,Heyndrickx L, Weber J, Quiñones-Mateu ME, Ariën KK, Vanham G.Human immunodeficiency virus type 1 resistance or cross-resistanceto nonnucleoside reverse transcriptase inhibitors currently underdevelopment as microbicides. Antimicrob Agents Chemother2011;55(4):1403-13.Smith NH, Berg S, Dale J, Allen A, Rodriguez S, Romero B, Matos F,Ghebremichael S, Karoui C, Donati C, Machado AD, Mucavele C,Kazwala RR, Hilty M, Cadmus S, Ngandolo BN, Habtamu M, Oloya J,Muller A, Milian-Suazo F, Andrievskaia O, Projahn M, Barandiarán S,Macías A, Müller B, Zanini MS, Ikuta CY, Rodriguez CA, Pinheiro SR,Figueroa A, Cho SN, Mosavari N, Chuang PC, Jou R, Zinsstag J, vanSoolingen D, Costello E, Aseffa A, Proaño-Perez F, Portaels F, Rigouts L,Cataldi AA, Collins DM, Boschiroli ML, Hewinson RG, Neto JS, SurujballiO, Tadyon K, Botelho A, Zarraga AM, Buller N, Skuce R, Michel A, AranazA, Kallenius G, Niemann S, Boniotti MB, van Helden PD, Harris B,Zumárraga MJ, Kremer K, Gordon SV, Jeon BY. European 1: a globallyimportant clonal complex of Mycobacterium bovis. Infect Genet Evol2011;11(6):1340-51.Sopoh GE, Johnson RC, Anagonou SY, Barogui YT, Dossou AD, HouézoJG, Phanzu DM, Tente BH, Meyers WM, Portaels F. Buruli ulcer prevalenceand altitude, Benin [letter]. Emerg Infect Dis 2011;17(1):153-4.Spies FS, Ribeiro AW, Ramos DF, Ribeiro MO, Martin A, Palomino JC,Rossetti MLR, da Silva PEA, Zaha A. Streptomycin resistance andlineage-specific polymorphisms in Mycobacterium tuberculosis gidBgene. J Clin Microbiol 2011;49(7):2625-30.62 | ONDERZOEK